首页|期刊导航|肿瘤防治研究|中国食管癌高发地区市县级医院晚期及转移性食管癌的患者特征

中国食管癌高发地区市县级医院晚期及转移性食管癌的患者特征OA

Patient Characteristics of Advanced and Metastatic Esophageal Cancer Treated in County-or Prefecture-Level Hospitals in High-Incidence Areas of Esophageal Cancer in China

中文摘要英文摘要

目的 关注中国食管癌高发地区市/县级医院的晚期患者的一般特征和诊疗过程.方法 回顾性、观察性收集2022年1月1日至2024年6月1日期间来自六家医院有首次诊疗记录的晚期食管癌患者电子病历信息.采用描述性分析方法,对患者临床特征和治疗方案进行统计分析.结果 本研究共纳入322例食管癌患者,其中男性230例(71.4%),中位年龄69岁.270例有肿瘤诊断信息,其中 264 例(97.8%)因食管癌特异性症状就诊.281 例具备病理类型信息,以食管鳞状细胞癌为主,共254例(90.4%);235例有首诊方式记录,其中220 例(93.6%)经内镜确诊为食管癌.216例(67.1%)晚期患者由局部晚期进展而来.有126例(39.1%)患者接受过手术治疗,其中123例(97.6%)为R0切除,71例(56.3%)接受围手术期治疗.116例(36.0%)患者接受根治性放化疗.根治性手术患者中位无病生存期为13.9个月,根治性放化疗患者无病生存期为10.6个月.在晚期阶段,250例(77.6%)患者出现淋巴结转移,纵隔转移为最常见类型,176例(54.7%)患者发生器官转移,其中肺、肝和骨转移最为常见.医疗保障情况显示,79.8%(229/287)的患者来自6家医疗中心所在市/县,77.9%(232/298)享有居民医保,88.7%(274/309)患者在本研究中6家市/县级医疗中心开始晚期治疗.结论 本研究呈现了我国食管癌高发地区晚期食管癌患者独特的流行病学特征和临床病理特点,为深入探索我国晚期食管癌患者的疾病特征提供了重要的参考依据.

Objective To investigate the general characteristics and treatment processes of patients with advanced esophageal cancer(EC)treated in county-or prefecture-level hospitals in high-incidence areas of EC in China.Methods In this retrospective observational study,electronic medical records of patients with advanced EC were collected from six medical centers in high-incidence areas.Eligible patients had advanced EC and whose first medical contact was documented between January 1,2022,and June 1,2024.Descriptive statistical analyses were conducted to evaluate patient characteristics and treatment plans.Results A total of 322 EC patients were included,of whom 230 were male(71.4%).The median age was 69 years.Among the 270 patients with available tumor diagnosis information,264 patients(97.8%)presented with EC-specific symptoms.Of the 281 patients with pathological data,esophageal squamous cell carcinoma was the predominant type,accounting for 254 cases(90.4%).Among 235 patients with information on the initial diagnostic method,220(93.6%)were diagnosed through endoscopy.A total of 216 patients(67.1%)with advanced disease progressed from early or locally advanced stages.Surgical treatment was performed in 126 patients(39.1%),of whom 123(97.6%)achieved R0 resection,and 71(56.3%)of them received perioperative treatment.Definitive chemoradiotherapy was administered to 116 patients(36.0%).The median disease-free survival for patients undergoing radical surgery was 13.9 months,while that for patients treated with definitive chemoradiotherapy was 10.6 months.At the advanced stage,lymph node metastasis was observed in 250 patients(77.6%),with mediastinal lymph node metastasis being the most common type.Organ metastasis occurred in 176 patients(54.7%),most frequently involving the lungs,liver,and bones.Most patients(79.8%,229/287)were from the county or city where the hospoital was loacted,77.9%(232/298)were covered by resident basic medical insurance,and 88.7%(274/309)of patients initiated advanced treatment at the participating hospitals.Conclusion This study reveals the unique epidemiological,clinical,and pathological characteristics of patients with EC in high-incidence areas of China.The results provide an important reference for further exploration of this disease and its management.

蔡红伟;艾冬梅;赵献军;温尊北;张先如;徐杰

637400 阆中,阆中市人民医院肿瘤科053000 衡水,衡水市第二人民医院肿瘤内科456550 林州,林州市肿瘤医院胸外科525200 高州,高州市人民医院肿瘤内科244000 铜陵,铜陵市人民医院肿瘤内科226600 海安,海安市人民医院肿瘤科

医药卫生

晚期食管癌高发地区市/县级医院真实世界研究

Advanced esophageal can-cerHigh-incidence areasHospitals in county-or prefecture-level citiesReal-world study

《肿瘤防治研究》 2026 (8)

609-615,7

10.3971/j.issn.1000-8578.2026.25.0959

评论